Successful Utilization of the GLP-1 Receptor Agonist Semaglutide in Treating the Manifestations of Recalcitrant Celiac Disease. (2025). Archives of Clinical and Biomedical Research, 9(5), 392-395. https://fortunejournals.org/ojs/index.php/acbr/article/view/15136